MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.atherosclerosis.2019.08.015

Медицинская библиотека · Atherosclerosis · 2019

Comparison of lipoprotein (a) serum concentrations measured by six commercially available immunoassays.

Scharnagl Hubert, Stojakovic Tatjana, Dieplinger Benjamin, Dieplinger Hans, Erhart Gertraud, Kostner Gerhard M, Herrmann Markus, März Winfried, Grammer Tanja B

Сравнительное исследованиеСтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND AND AIMS: Lipoprotein (a) [Lp(a)] is an established causal risk factor for cardiovascular disease (CVD), independently of low-density lipoproteins (LDL) and other risk factors. The recognition of Lp(a) as an atherogenic molecule has raised the demand for reliable quantification methods in the clinical laboratory. The aim of this work is to compare commercial immunochemical assays.

METHODS

We measured Lp(a) serum concentrations using six different assays, providing Lp(a) in mg/dl (Denka Seiken, Abbott Quantia, Beckman, Diasys 21FS, and Siemens N Latex) or in nmol/l (Roche TinaQuant, Diasys 21 FS) in 144 serum samples covering the clinically relevant range of Lp(a) concentrations. All assays relied on five-point calibrations using calibrators provided by the manufacturers. Apolipoprotein(a) phenotyping was performed by sodium dodecyl sulfate-agarose gel electrophoresis (SDS-agarose) followed by immunoblotting.

RESULTS

Most bivariate correlation coefficients were greater than 0.90. Compared to an established IFCC-proposed reference material, the results of the different assays diverged from the target values (43.3 mg/dl or 96.6 nmol/l) by -8% (Siemens N Latex) and +22% (Abbott Quantia). Stratification of the samples into five groups with increasing Lp(a) concentrations and difference plots showed that the differences among assays were concentration-dependent. Some assays overestimated Lp(a) at high concentrations compared to the Denka Seiken assay.

CONCLUSIONS

Current commercial immunological assays for measuring Lp(a) concentrations are differently calibrated. Their biases differ significantly across the clinically relevant concentration range in a non-linear manner. This is not conclusively explained by apolipoprotein (a) phenotypes. Further international efforts to harmonize assays for Lp(a) are needed.

Для цитирования: Scharnagl Hubert, Stojakovic Tatjana, Dieplinger Benjamin, Dieplinger Hans, Erhart Gertraud, Kostner Gerhard M, Herrmann Markus, März Winfried, Grammer Tanja B. Comparison of lipoprotein (a) serum concentrations measured by six commercially available immunoassays.. Atherosclerosis. 2019. DOI: 10.1016/j.atherosclerosis.2019.08.015.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.